Apr 23, 09:07
100% of moneycontrol users recommend buying Granules India.
What's your call on Granules India today?
Read 66 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2569.90||0.67||2939.80||1904.15||43,716.28|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Granules India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 627.02 crore.The company has reported a consolidated sales of Rs 284.05 crore and a Net Profit of Rs 21.81 crore for the quarter ended Dec 2013.
The company management includes C Nageswara Rao - Chairman, C Krishna Prasad - Managing Director, L S Sarma - Director, A P Kurian - Director, C Parthasarathy - Director, Krishna Murthy Ella - Director, Arun Rao Akinepally - Director, Harsha Chigurupati - Executive Director, Uma Chigurupati - Executive Director, K B Sankara Rao - Additional Director.
It is listed on the BSE with a BSE Code of 532482 and the NSE with an NSE Code of GRANULES.
Its Registered office is at 2nd Floor, 3rd Block,,My Home Hub, Hyderabad,Andhra Pradesh - 500081.
Their Registrars are Cil Securities Ltd.